Literature DB >> 2655431

Physiotherapy for children with cerebral palsy. Evidence for its efficacy.

E Tirosh1, S Rabino.   

Abstract

Physiotherapy is currently the most popular therapeutic intervention for cerebral palsy. This therapy requires highly trained personnel, diverse equipment, and parental cooperation. Notwithstanding the expense and commitment required for the implementation of a therapeutic program, a computer search of the literature published in English during the past 15 years revealed only nine studies pertaining to the efficacy and no study addressing the effectiveness of this intervention. A critical review of this literature, employing 14 methodological and reporting criteria, revealed that only three studies adequately fulfilled nine of the criteria; the remaining studies used a less rigorous design. Of those three articles, two used statistical analysis and concluded that the results were negative, while the third utilized clinical analysis only and demonstrated positive results. Evidence for the usefulness of this therapy has yet to be demonstrated; with the presently available methodologies it is ethically imperative to institute a properly designed, collaborative, multicenter, randomized, controlled trial.

Entities:  

Mesh:

Year:  1989        PMID: 2655431     DOI: 10.1001/archpedi.1989.02150170050020

Source DB:  PubMed          Journal:  Am J Dis Child        ISSN: 0002-922X


  3 in total

1.  Rehabilitation in cerebral palsy.

Authors:  G E Molnar
Journal:  West J Med       Date:  1991-05

2.  Factors Influencing Utilization of Physiotherapy Service among Children with Cerebral Palsy in Jalandhar District of Punjab.

Authors:  Akhoury Gourang Sinha; Raju Sharma
Journal:  J Neurosci Rural Pract       Date:  2017 Apr-Jun

Review 3.  Effectiveness of physical therapy interventions for children with cerebral palsy: a systematic review.

Authors:  Heidi Anttila; Ilona Autti-Rämö; Jutta Suoranta; Marjukka Mäkelä; Antti Malmivaara
Journal:  BMC Pediatr       Date:  2008-04-24       Impact factor: 2.125

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.